Syngene International Ltd Falls to 52-Week Low of Rs.560.9 Amidst Continued Downtrend

Stock Price Movement and Market Context

On 23 Jan 2026, Syngene International Ltd opened with a gap down of -2.08%, continuing its losing streak for the eighth consecutive day. The stock’s intraday low of Rs.560.9 represents a decline of -5.28% on the day and a cumulative loss of -6.93% over the past eight sessions. This performance contrasts with the broader market, where the Sensex showed marginal gains, trading at 82,319.06, up 0.01% after a flat opening. The Sensex remains 4.66% below its 52-week high of 86,159.02, while mid-cap stocks led gains with a 0.14% rise in the BSE Mid Cap index.

Syngene’s stock has also underperformed its healthcare services sector by -0.48% today. The share price is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. Intraday volatility was elevated at 5.48%, reflecting heightened uncertainty among market participants.

Financial Performance and Valuation Metrics

Syngene International’s recent quarterly results have contributed to the subdued market sentiment. For the quarter ended December 2025, the company reported a Profit Before Tax (PBT) of Rs.83.60 crores, down by -37.8% compared to the average of the previous four quarters. Net Profit After Tax (PAT) declined even more sharply by -55.3% to Rs.52.29 crores, with Earnings Per Share (EPS) falling to a low of Rs.0.37 for the quarter.

Over the last five years, Syngene’s net sales have grown at a compound annual growth rate (CAGR) of 12.63%, while operating profit has increased at a slower pace of 9.01%. Despite this growth, the company’s return on equity (ROE) stands at a modest 9.9%, which, when combined with a price-to-book (P/B) ratio of 5, indicates a relatively expensive valuation compared to peers.

Over the past year, the stock has generated a negative return of -31.11%, significantly lagging the Sensex’s positive 7.58% gain. Meanwhile, the company’s profits have increased marginally by 1.6%, resulting in a high price/earnings to growth (PEG) ratio of 34.5. This disparity between price performance and earnings growth highlights valuation pressures weighing on the stock.

Long-Term and Recent Performance Trends

Syngene International’s stock has demonstrated below-par performance over multiple time horizons. In addition to the -31.11% return over the last year, the stock has underperformed the BSE500 index over the past three years, one year, and three months. This persistent underperformance reflects challenges in sustaining growth momentum and investor confidence.

The company’s market capitalisation grade stands at 3, indicating a mid-tier valuation relative to market peers. The Mojo Score of 28.0 and a recent downgrade from a ‘Sell’ to a ‘Strong Sell’ rating on 19 Jan 2026 further underline the cautious stance adopted by rating agencies and analysts.

Balance Sheet and Shareholding Structure

On the balance sheet front, Syngene International maintains a conservative capital structure with an average debt-to-equity ratio of zero, signalling no reliance on debt financing. This low leverage reduces financial risk but has not translated into stronger market performance.

Institutional investors hold a significant 40.8% stake in the company. Such holdings typically reflect thorough fundamental analysis and suggest that these investors have assessed the company’s prospects carefully, despite the recent price weakness.

Summary of Key Metrics

To summarise, Syngene International Ltd’s stock is currently trading at Rs.560.9, its lowest level in the past 52 weeks, down from a high of Rs.862. The stock’s recent performance includes:

• Eight consecutive days of decline, with a cumulative loss of -6.93%


• Underperformance relative to the healthcare services sector and broader market indices


• Quarterly PBT and PAT declines of -37.8% and -55.3% respectively


• EPS at a quarterly low of Rs.0.37


• Valuation metrics indicating a premium price-to-book ratio of 5 and a PEG ratio of 34.5


• Strong institutional ownership at 40.8%

These factors collectively illustrate the current market environment surrounding Syngene International Ltd, highlighting the challenges reflected in its share price movement and financial indicators.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →